EXACT Therapeutics AS - Notice of Annual General Meeting 2024

14 Jun 2024 09:00 CEST

OSLO, June 14, 2024: The Annual General Meeting of EXACT Therapeutics AS
(“EXACT-Tx”, Euronext Growth: EXTX), will be held as a virtual meeting at 10:30
CEST on 28th June 2024.

The notice of the Annual General Meeting with Attendance/Proxy forms, including
the Board of Directors' proposed resolutions for the items listed on the agenda.
The documents are also available at www.exact-tx.com. The deadline for receiving
proxies or attendance registration is 26th June 2024 at 12:00 CEST.



For more information, please contact:

Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com

John M. Edminson, CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com

About EXACT-Tx
EXACT-Tx is a clinical-stage Norwegian precision health company developing a
technology platform for targeted therapeutic enhancement – Acoustic Cluster
Therapy (ACT®). ACT® follows a unique approach to ultrasound-mediated, targeted
drug enhancement – with the potential to enable or significantly amplify the
clinical utility of a wide range of therapeutic agents across a multitude of
indications including within oncology (chemotherapy, immunotherapy) and brain
diseases. www.exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site

621503_AGM Notice - EXACT Therapeutics AS 28 june 2024 .pdf